PURPOSE: To develop a compressed sensing (CS) acceleration method with a high spectral bandwidth exploiting the spatial-spectral sparsity of MR spectroscopic imaging (MRSI). METHODS: Accelerations were achieved using blip gradients during the readout to perform nonoverlapped and stochastically delayed random walks in kx -ky -t space, combined with block-Hankel matrix completion for efficient reconstruction. Both retrospective and prospective CS accelerations were applied to (13) C MRSI experiments, including in vivo rodent brain and liver studies with administrations of hyperpolarized [1-(13) C] pyruvate at 7.0 Tesla (T) and [2-(13) C] dihydroxyacetone at 3.0 T, respectively. RESULTS: In retrospective undersampling experiments using in vivo 7.0 T data, the proposed method preserved spectral, spatial, and dynamic fidelities with R(2) ≥ 0.96 and ≥ 0.87 for pyruvate and lactate signals, respectively, 750-Hz spectral separation, and up to 6.6-fold accelerations. In prospective in vivo experiments, with 3.8-fold acceleration, the proposed method exhibited excellent spatial localization of metabolites and peak recovery for pyruvate and lactate at 7.0 T as well as for dihydroxyacetone and its metabolic products with a 4.5-kHz spectral span (140 ppm at 3.0 T). CONCLUSIONS: This study demonstrated the feasibility of a new CS approach to accelerate high spectral bandwidth MRSI experiments. Magn Reson Med 76:369-379, 2016.
PURPOSE: To develop a compressed sensing (CS) acceleration method with a high spectral bandwidth exploiting the spatial-spectral sparsity of MR spectroscopic imaging (MRSI). METHODS: Accelerations were achieved using blip gradients during the readout to perform nonoverlapped and stochastically delayed random walks in kx -ky -t space, combined with block-Hankel matrix completion for efficient reconstruction. Both retrospective and prospective CS accelerations were applied to (13) C MRSI experiments, including in vivo rodent brain and liver studies with administrations of hyperpolarized [1-(13) C] pyruvate at 7.0 Tesla (T) and [2-(13) C] dihydroxyacetone at 3.0 T, respectively. RESULTS: In retrospective undersampling experiments using in vivo 7.0 T data, the proposed method preserved spectral, spatial, and dynamic fidelities with R(2) ≥ 0.96 and ≥ 0.87 for pyruvate and lactate signals, respectively, 750-Hz spectral separation, and up to 6.6-fold accelerations. In prospective in vivo experiments, with 3.8-fold acceleration, the proposed method exhibited excellent spatial localization of metabolites and peak recovery for pyruvate and lactate at 7.0 T as well as for dihydroxyacetone and its metabolic products with a 4.5-kHz spectral span (140 ppm at 3.0 T). CONCLUSIONS: This study demonstrated the feasibility of a new CS approach to accelerate high spectral bandwidth MRSI experiments. Magn Reson Med 76:369-379, 2016.
Authors: Ralph E Hurd; Yi-Fen Yen; Dirk Mayer; Albert Chen; David Wilson; Susan Kohler; Robert Bok; Daniel Vigneron; John Kurhanewicz; James Tropp; Daniel Spielman; Adolf Pfefferbaum Journal: Magn Reson Med Date: 2010-05 Impact factor: 4.668
Authors: Simon Hu; Michael Lustig; Albert P Chen; Jason Crane; Adam Kerr; Douglas A C Kelley; Ralph Hurd; John Kurhanewicz; Sarah J Nelson; John M Pauly; Daniel B Vigneron Journal: J Magn Reson Date: 2008-03-18 Impact factor: 2.229
Authors: Peder E Z Larson; Robert Bok; Adam B Kerr; Michael Lustig; Simon Hu; Albert P Chen; Sarah J Nelson; John M Pauly; John Kurhanewicz; Daniel B Vigneron Journal: Magn Reson Med Date: 2010-03 Impact factor: 4.668
Authors: Dirk Mayer; Yi-Fen Yen; Yakir S Levin; James Tropp; Adolf Pfefferbaum; Ralph E Hurd; Daniel M Spielman Journal: J Magn Reson Date: 2010-03-09 Impact factor: 2.229
Authors: Ralph E Hurd; Yi-Fen Yen; James Tropp; Adolf Pfefferbaum; Daniel M Spielman; Dirk Mayer Journal: J Cereb Blood Flow Metab Date: 2010-06-30 Impact factor: 6.200
Authors: Ilwoo Park; Peder E Z Larson; Matthew L Zierhut; Simon Hu; Robert Bok; Tomoko Ozawa; John Kurhanewicz; Daniel B Vigneron; Scott R Vandenberg; C David James; Sarah J Nelson Journal: Neuro Oncol Date: 2010-01-25 Impact factor: 12.300
Authors: Jan H Ardenkjaer-Larsen; Björn Fridlund; Andreas Gram; Georg Hansson; Lennart Hansson; Mathilde H Lerche; Rolf Servin; Mikkel Thaning; Klaes Golman Journal: Proc Natl Acad Sci U S A Date: 2003-08-20 Impact factor: 11.205
Authors: Peder E Z Larson; Adam B Kerr; Albert P Chen; Michael S Lustig; Matthew L Zierhut; Simon Hu; Charles H Cunningham; John M Pauly; John Kurhanewicz; Daniel B Vigneron Journal: J Magn Reson Date: 2008-06-24 Impact factor: 2.229
Authors: Sarmad Siddiqui; Stephen Kadlecek; Mehrdad Pourfathi; Yi Xin; William Mannherz; Hooman Hamedani; Nicholas Drachman; Kai Ruppert; Justin Clapp; Rahim Rizi Journal: Adv Drug Deliv Rev Date: 2016-09-04 Impact factor: 15.470
Authors: L McCarthy; G Verma; G Hangel; A Neal; B A Moffat; J P Stockmann; O C Andronesi; P Balchandani; C G Hadjipanayis Journal: AJNR Am J Neuroradiol Date: 2022-05-26 Impact factor: 4.966
Authors: Jeremy W Gordon; Hsin-Yu Chen; Nicholas Dwork; Shuyu Tang; Peder E Z Larson Journal: J Magn Reson Imaging Date: 2020-02-10 Impact factor: 5.119
Authors: Geoffrey J Topping; Christian Hundshammer; Luca Nagel; Martin Grashei; Maximilian Aigner; Jason G Skinner; Rolf F Schulte; Franz Schilling Journal: MAGMA Date: 2019-12-06 Impact factor: 2.310
Authors: Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher Journal: NMR Biomed Date: 2020-04-29 Impact factor: 4.044